Seven new research projects on regenerative medicine and nanomedicine at Canadian universities received $16 million in funding. The studies, co-funded by the Canadian Institutes of Health Research (CIHR) and the Canadian Space Agency (CSA), were announced at the University of Toronto on March 16, 2011.
Nanomedicine delivers medical technologies that detect or function at the molecular level to diagnose and treat disease, while regenerative medicine stimulates the renewal of bodily tissues and organs or restores function through natural and bioengineered means. Various innovations in these areas have helped combat vascular diseases, cancer, diabetes, multiple sclerosis and other chronic diseases.
This funding will enable two UBC researchers to potentially:
- create personalized nanomedicines that silence cancer-causing genes, Prof. Pieter Cullis, Biochemistry and Molecular Biology
- generate transplantable, insulin-producing cells from stem cells for diabetes, Prof. Timothy Kieffer, Surgery, Cellular & Physiological Sciences
For more information, visit http://www.med.ubc.ca/media/201103/Faculty_members_wins_CIHR_nanomedicine_and_regenerative_medicine_grants.htm
